Email
Print
Biotherapeutics Cell Line Development Market - Forecast(2024 - 2030)
1. Biotherapeutics Cell Line Development Market - Overview
1.1 Definitions and Scope
2. Biotherapeutics Cell Line Development Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biotherapeutics Cell Line Development Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biotherapeutics Cell Line Development Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biotherapeutics Cell Line Development Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biotherapeutics Cell Line Development Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biotherapeutics Cell Line Development Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biotherapeutics Cell Line Development Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Biotherapeutics Cell Line Development Market - By Type(Market Size -$Million / $Billion)
9.1 Biotherapeutics Cell Line Development , by Process,
9.1.1 Transfection Selection
9.1.2 Single Cell Cloning
9.1.2.1 Manual Limited Dilution Cloning
9.1.2.2 FACS
9.1.2.3 ClonePix
9.2 Biotherapeutics Cell Line Development , by CLD Option,
9.2.1 In-house
9.2.2 Outsource
9.2.3 Do-it-yourself
9.2.4 Hybrid
10. Biotherapeutics Cell Line Development - By Application Type(Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Biotherapeutics Cell Line Development- By Geography (Market Size -$Million / $Billion)
11.1 Biotherapeutics Cell Line Development Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biotherapeutics Cell Line Development- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biotherapeutics Cell Line Development- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biotherapeutics Cell Line Development - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biotherapeutics Cell Line Development - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biotherapeutics Cell Line Development Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biotherapeutics Cell Line Development Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biotherapeutics Cell Line Development Market - Key Company List by Country Premium
15. Biotherapeutics Cell Line Development Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Beckman Coulter, Inc.
15.3 Becton, Dickinson and Company
15.4 Boehringer Ingelheim Pharma GmbH Co KG.
15.5 CMC Biologics
15.6 Catalent, Inc.
15.7 Lonza Group Ltd.
15.8 Partec
15.9 ProBioGen AG
15.10 SAFC
15.11 Selexis SA
15.12 Sony Biotechnology Inc.
15.13 Thermo Fisher Scientific, Inc.
15.14 Company 14
15.15 Company 15 & More
16.1 Abbreviations
16.2 Sources
17. Biotherapeutics Cell Line Development Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Biotherapeutics Cell Line Development Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biotherapeutics Cell Line Development Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biotherapeutics Cell Line Development Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biotherapeutics Cell Line Development Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biotherapeutics Cell Line Development Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biotherapeutics Cell Line Development Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biotherapeutics Cell Line Development Market - By Product Type(Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Biotherapeutics Cell Line Development Market - By Type(Market Size -$Million / $Billion)
9.1 Biotherapeutics Cell Line Development , by Process,
9.1.1 Transfection Selection
9.1.2 Single Cell Cloning
9.1.2.1 Manual Limited Dilution Cloning
9.1.2.2 FACS
9.1.2.3 ClonePix
9.2 Biotherapeutics Cell Line Development , by CLD Option,
9.2.1 In-house
9.2.2 Outsource
9.2.3 Do-it-yourself
9.2.4 Hybrid
10. Biotherapeutics Cell Line Development - By Application Type(Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
11. Biotherapeutics Cell Line Development- By Geography (Market Size -$Million / $Billion)
11.1 Biotherapeutics Cell Line Development Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biotherapeutics Cell Line Development- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biotherapeutics Cell Line Development- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biotherapeutics Cell Line Development - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biotherapeutics Cell Line Development - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biotherapeutics Cell Line Development Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biotherapeutics Cell Line Development Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biotherapeutics Cell Line Development Market - Key Company List by Country Premium
15. Biotherapeutics Cell Line Development Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Beckman Coulter, Inc.
15.3 Becton, Dickinson and Company
15.4 Boehringer Ingelheim Pharma GmbH Co KG.
15.5 CMC Biologics
15.6 Catalent, Inc.
15.7 Lonza Group Ltd.
15.8 Partec
15.9 ProBioGen AG
15.10 SAFC
15.11 Selexis SA
15.12 Sony Biotechnology Inc.
15.13 Thermo Fisher Scientific, Inc.
15.14 Company 14
15.15 Company 15 & More
*Financials would be provided on a best efforts basis for private companies
16. Biotherapeutics Cell Line Development Market - Appendix16.1 Abbreviations
16.2 Sources
17. Biotherapeutics Cell Line Development Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Biotherapeutics Cell Line Development , by Process, Market 2023-2030 ($M)1.1 Transfection Selection Market 2023-2030 ($M) - Global Industry Research
1.2 Single Cell Cloning Market 2023-2030 ($M) - Global Industry Research
1.2.1 Manual Limited Dilution Cloning Market 2023-2030 ($M)
1.2.2 FACS Market 2023-2030 ($M)
1.2.3 ClonePix Market 2023-2030 ($M)
2.Global Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 ($M)
2.1 In-house Market 2023-2030 ($M) - Global Industry Research
2.2 Outsource Market 2023-2030 ($M) - Global Industry Research
2.3 Do-it-yourself Market 2023-2030 ($M) - Global Industry Research
2.4 Hybrid Market 2023-2030 ($M) - Global Industry Research
3.Global Biotherapeutics Cell Line Development , by Process, Market 2023-2030 (Volume/Units)
3.1 Transfection Selection Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Single Cell Cloning Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Manual Limited Dilution Cloning Market 2023-2030 (Volume/Units)
3.2.2 FACS Market 2023-2030 (Volume/Units)
3.2.3 ClonePix Market 2023-2030 (Volume/Units)
4.Global Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 (Volume/Units)
4.1 In-house Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Outsource Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Do-it-yourself Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Hybrid Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Biotherapeutics Cell Line Development , by Process, Market 2023-2030 ($M)
5.1 Transfection Selection Market 2023-2030 ($M) - Regional Industry Research
5.2 Single Cell Cloning Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Manual Limited Dilution Cloning Market 2023-2030 ($M)
5.2.2 FACS Market 2023-2030 ($M)
5.2.3 ClonePix Market 2023-2030 ($M)
6.North America Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 ($M)
6.1 In-house Market 2023-2030 ($M) - Regional Industry Research
6.2 Outsource Market 2023-2030 ($M) - Regional Industry Research
6.3 Do-it-yourself Market 2023-2030 ($M) - Regional Industry Research
6.4 Hybrid Market 2023-2030 ($M) - Regional Industry Research
7.South America Biotherapeutics Cell Line Development , by Process, Market 2023-2030 ($M)
7.1 Transfection Selection Market 2023-2030 ($M) - Regional Industry Research
7.2 Single Cell Cloning Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Manual Limited Dilution Cloning Market 2023-2030 ($M)
7.2.2 FACS Market 2023-2030 ($M)
7.2.3 ClonePix Market 2023-2030 ($M)
8.South America Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 ($M)
8.1 In-house Market 2023-2030 ($M) - Regional Industry Research
8.2 Outsource Market 2023-2030 ($M) - Regional Industry Research
8.3 Do-it-yourself Market 2023-2030 ($M) - Regional Industry Research
8.4 Hybrid Market 2023-2030 ($M) - Regional Industry Research
9.Europe Biotherapeutics Cell Line Development , by Process, Market 2023-2030 ($M)
9.1 Transfection Selection Market 2023-2030 ($M) - Regional Industry Research
9.2 Single Cell Cloning Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Manual Limited Dilution Cloning Market 2023-2030 ($M)
9.2.2 FACS Market 2023-2030 ($M)
9.2.3 ClonePix Market 2023-2030 ($M)
10.Europe Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 ($M)
10.1 In-house Market 2023-2030 ($M) - Regional Industry Research
10.2 Outsource Market 2023-2030 ($M) - Regional Industry Research
10.3 Do-it-yourself Market 2023-2030 ($M) - Regional Industry Research
10.4 Hybrid Market 2023-2030 ($M) - Regional Industry Research
11.APAC Biotherapeutics Cell Line Development , by Process, Market 2023-2030 ($M)
11.1 Transfection Selection Market 2023-2030 ($M) - Regional Industry Research
11.2 Single Cell Cloning Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Manual Limited Dilution Cloning Market 2023-2030 ($M)
11.2.2 FACS Market 2023-2030 ($M)
11.2.3 ClonePix Market 2023-2030 ($M)
12.APAC Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 ($M)
12.1 In-house Market 2023-2030 ($M) - Regional Industry Research
12.2 Outsource Market 2023-2030 ($M) - Regional Industry Research
12.3 Do-it-yourself Market 2023-2030 ($M) - Regional Industry Research
12.4 Hybrid Market 2023-2030 ($M) - Regional Industry Research
13.MENA Biotherapeutics Cell Line Development , by Process, Market 2023-2030 ($M)
13.1 Transfection Selection Market 2023-2030 ($M) - Regional Industry Research
13.2 Single Cell Cloning Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Manual Limited Dilution Cloning Market 2023-2030 ($M)
13.2.2 FACS Market 2023-2030 ($M)
13.2.3 ClonePix Market 2023-2030 ($M)
14.MENA Biotherapeutics Cell Line Development , by CLD Option, Market 2023-2030 ($M)
14.1 In-house Market 2023-2030 ($M) - Regional Industry Research
14.2 Outsource Market 2023-2030 ($M) - Regional Industry Research
14.3 Do-it-yourself Market 2023-2030 ($M) - Regional Industry Research
14.4 Hybrid Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)2.Canada Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
3.Mexico Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
4.Brazil Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
5.Argentina Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
6.Peru Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
7.Colombia Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
8.Chile Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
9.Rest of South America Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
10.UK Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
11.Germany Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
12.France Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
13.Italy Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
14.Spain Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
15.Rest of Europe Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
16.China Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
17.India Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
18.Japan Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
19.South Korea Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
20.South Africa Biotherapeutics Cell Line Development Market Revenue, 2023-2030 ($M)
21.North America Biotherapeutics Cell Line Development By Application
22.South America Biotherapeutics Cell Line Development By Application
23.Europe Biotherapeutics Cell Line Development By Application
24.APAC Biotherapeutics Cell Line Development By Application
25.MENA Biotherapeutics Cell Line Development By Application
26.Becton, Dickinson and Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Beckman Coulter, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Boehringer Ingelheim Pharma GmbH Co KG., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Catalent, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.CMC Biologics, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Lonza Group Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Partec, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.ProBioGen AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.SAFC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Selexis SA, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Sony Biotechnology Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Thermo Fisher Scientific, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)